Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier ...
Poster will characterize the efficacy of PIKTOR as a monotherapy and in combination with fulvestrant, oral SERDs, and CDK inhibitors in preclinical models of breast cancer; Poster ...
In this newly created executive role, Ms. Roberson will lead the company's global talent and organizational strategy, with a ...
Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany. Paris and Frankfurt, October 19, 2026 ...
Marvel Biosciences Corp. (TSXV: MRVL \| OTCQB: MBCOF), and its wholly-owned subsidiary, Marvel Biotechnology Inc.
Takeda (TSE:4502/NYSE:TAK) announced new data from VERDICT (NCT04259138), showing that treating adults with intravenous ...
Dr. Weber, an otologist and neurotologist who led the clinical development of the first FDA-approved gene therapy for genetic ...
Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a ...
Partnership with Vanderbilt University and Vanderbilt Health accelerates development of the first radiomics-based test for ...
Quanta Therapeutics, a privately held, clinical-stage biopharmaceutical company leading the development of innovative ...
Nutex Health, Inc. (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 28 state-of-the-art ...
Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio ® ” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have ...